Company Filing History:
Years Active: 2000
Title: Johannes A VanBeek: Innovator in Cyclopentadiene Compounds
Introduction
Johannes A VanBeek is a notable inventor based in Maastricht, Netherlands. He has made significant contributions to the field of chemistry, particularly in the development of cyclopentadiene compounds. His innovative work has led to the creation of a unique patent that showcases his expertise and creativity.
Latest Patents
Johannes A VanBeek holds a patent for a "Cyclopentadiene compound substituted with a hetero atom-containing group." This polysubstituted cyclopentadiene-containing compound features at least one substituent with the formula --RDR'.sub.n. In this formula, R serves as a linking group between the cyclopentadiene and the DR'.sub.n group, while D is a hetero atom selected from group 15 or 16 of the Periodic Table of Elements or an aryl group. The compound is designed to have R with a length of at least an ethylene group, and R' is a hydrocarbon radical containing 1-20 carbon atoms, including various forms such as alkyl, aryl, and aralkyl. The number of R' groups bound to D is represented by n, which may consist of identical or different groups.
Career Highlights
Johannes A VanBeek is currently associated with DSM N.V., a leading company in the field of health, nutrition, and materials. His work at DSM N.V. has allowed him to further his research and development efforts in innovative chemical compounds. His contributions have been instrumental in advancing the company's objectives and enhancing its product offerings.
Collaborations
Johannes A VanBeek collaborates with Gerardus J Gruter, a fellow innovator in the field. Their partnership has fostered a creative environment that encourages the exploration of new ideas and the development of groundbreaking technologies.
Conclusion
Johannes A VanBeek is a distinguished inventor whose work in cyclopentadiene compounds has made a significant impact in the field of chemistry. His innovative patent and collaboration with other experts highlight his commitment to advancing scientific knowledge and technology.